[HTML][HTML] Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker …

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - Springer
Abstract Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have
various physiological and pathological functions by post-transcriptional regulation of gene …

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - europepmc.org
Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various
physiological and pathological functions by post-transcriptional regulation of gene …

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - search.proquest.com
Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various
physiological and pathological functions by post-transcriptional regulation of gene …

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - search.ebscohost.com
Abstract Background: Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have
various physiological and pathological functions by post-transcriptional regulation of gene …

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various
physiological and pathological functions by post-transcriptional regulation of gene …

[HTML][HTML] Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker …

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various
physiological and pathological functions by post-transcriptional regulation of gene …

[HTML][HTML] Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker …

M Nemecz, DS Stefan… - Cardiovascular …, 2023 - cardiab.biomedcentral.com
Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological
and pathological functions by post-transcriptional regulation of gene expression being …

[PDF][PDF] Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker …

M Nemecz, DS Stefan, IK Comarița, A Constantin… - 2023 - cardiab.biomedcentral.com
Abstract Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have
various physiological and pathological functions by post-transcriptional regulation of gene …

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.

M Nemecz, DS Stefan, IK Comarița… - Cardiovascular …, 2023 - europepmc.org
Background Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various
physiological and pathological functions by post-transcriptional regulation of gene …